Common oral lesions: Part I. Superficial mucosal lesions

American Family Physician

Volumn 75, Issue 4, 2007, Pages 501-507

  Gonsalves, Wanda C ^a,b   Chi, Angela C ^a   Neville, Brad W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMLEXANOX; CHLORHEXIDINE GLUCONATE; FARNVIR; FLUCONAZOLE; FLUOCINONIDE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; PENCICLOVIR; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VALACICLOVIR;

APHTHOUS STOMATITIS; ARTICLE; ERYTHEMA CHRONICUM MIGRANS; HAIRY TONGUE; HERPES LABIALIS; HUMAN; LICHEN PLANUS; MOUTH LESION; MOUTHWASH; THRUSH; MOUTH DISEASE; REVIEW; RISK FACTOR;

HUMANS; MOUTH DISEASES; RISK FACTORS;

EID: 33847711495     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Evans CA, Kleinman DV. The Surgeon General's report on America's oral health: opportunities for the dental profession [Published correction appears in J Am Dent Assoc 2001;132:444]. J Am Dent Assoc 2000;131:1721-8.
2. Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Dent Assoc 2004;135:1279-86.
3. Bouquot JE. Common oral lesions found during a mass screening examination. J Am Dent Assoc 1986;112:50-7.
4. Fotos PG, Vincent SD, Hellstein JW. Oral candidosis. Clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1992;74:41-9.
5. Neville BW. Candidiasis. In: Oral and Maxillofacial Pathology. Philadelphia, Pa.: Saunders, 2002:189-97.
6. Epstein JB, Gorsky M, Caldwell J. Fluconazole mouth-rinses for oral candidiasis in postirradiation, transplant, and other patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:671-5.
7. Pankhurst C. Candidiasis (oropharyngeal). Clin Evid 2005;13:1701-16.
8. Patton LL, Bonito AJ, Shugars DA. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:170-9.
9. Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev Anti Infect Ther 2004;2:357-66.
10. Neville BW. Herpes simplex virus. In: Oral and Maxillofacial Pathology. Philadelphia, Pa.: Saunders, 2002:213-20.
11. Spruance SL, Jones TM, Blatter MM, Vargas-Cortes M, Barber J, Hill J, et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother 2003;47:1072-80.
12. Raborn GW, Martel AY, Lassonde M, Lewis MA, Boon R, Spruance SL, et al., for the Worldwide Topical Penciclovir Collaborative Study Group. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc 2002;133:303-9.
13. Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-72.
14. Spruance SL. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol 1993;(suppl 1):27-32.
15. Porter S, Scully C. Aphthous ulcers (recurrent). Clin Evid 2005;13:1687-94.
16. Greer RO Jr, Lindenmuth JE, Juarez T, Khandwala A. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993;51:243-8.
17. Ramirez-Amador VA, Esquivel-Pedraza L, Ponce-de-Leon S, Reyes-Teran G, Gonzalez-Guevara M, Ponce-de-Leon S, et al. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial. Clin Infect Dis 1999;28:892-4.
18. Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign migratory glossitis or geographic tongue: an enigmatic oral lesion. Am J Med 2002;113(9):751-5.
19. Harada Y, Gaafar H. Black hairy tongue. A scanning electron microscopic study. J Laryngol Otol 1977;91:91-6.
20. Heymann WR. Psychotropic agent-induced black hairy tongue. Cutis 2000;66:25-6.
21. Sarti GM, Haddy RI, Schaffer D, Kihm J. Black hairy tongue. Am Fam Physician 1990;41:1751-5.
22. Chan ES, Thornhill M, Zakrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev 1999;(2):CD001168.
23. Gonsalves WC, Chi AC, Neville BW. Common oral lesions. Part II: Masses and neoplasia. Am Fam Physician 2007;75:509-12.
24. Ghannoum MA, Abu-Elteen KH. Pathogenicity determinants of Candida. Mycoses 1990;33:265-82.
25. Abu-Elteen KH, Abu-Elteen RM. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 1998;21:41-8.
26. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004;42:1519-27.
27. Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J 2005;24:601-4.
28. Goins RA, Ascher D, Waecker N, Arnold J, Moorefield E. Comparison of fluconazole and nystatin oral suspensions for treatments of oral candidiasis in infants. Pediatr Infect Dis J 2002;21:1165-7.
29. Hoppe JE. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J 1997;16:885-94.
30. Worrall G. Herpes labialis. Clin Evid 2004;12:2312-20.
31. Weston WL, Morelli JG. Herpes simplex virus-associated erythema multiforme in prepubertal children. Arch Pediatr Adolesc Med 1997;151:1014-6.
32. Tatnall FM, Schofield JK, Leigh IM. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995;132:267-70.
33. Rivera-Hidalgo F, Shulman JD, Beach MM. The association of tobacco and other factors with recurrent aphthous stomatitis in an U.S. adult population. Oral Dis 2004;10:335-45.
34. Neville BW. Recurrent aphthous stomatitis (recurrent aphthous ulcerations; canker sores). In: Oral and Maxillofacial Pathology. Philadelphia, Pa.: Saunders, 2002:285-90.
35. Ogura M, Yamamoto T, Morita M, Watanabe T. A case-control study on food intake of patients with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:45-9.
36. Scully C. Clinical practice. Aphthous ulceration. N Engl J Med 2006;355:165-72.
37. Pimlott SJ, Walker DM. A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration. Br Dent J 1983;154:174-7.
38. Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M. Oral lichen planus. Clin Dermatol 2000;18:533-9.
39. Axell T, Rundquist L. Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 1987;15:52-6.
40. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002;46:207-14.